|
WO2008024769A2
|
|
Intensified perfusion production method
|
|
WO2008006036A2
|
|
Conditioned cell immunization
|
|
KR20070107721A
|
|
Antibodies that bind to epha2 and methods of use thereof
|
|
US2006172349A1
|
|
LUCA2 and antibodies that bind thereto
|
|
US2006166291A1
|
|
KID31 and antibodies that bind thereto
|
|
KR20060079236A
|
|
Kid3 and kid3 antibodies that bind thereto
|
|
US7462487B2
|
|
Cell culture media
|
|
US7405061B2
|
|
Antigen PIPA and antibodies that bind thereto
|
|
MXPA04012664A
|
|
Novel raag10 cell surface target and a family of antibodies recognizing that target.
|
|
CN1655671A
|
|
Animal model for toxicology and dose prediction
|
|
CN1662254A
|
|
ALCAM and ALCAM modulators
|
|
EP1492870A2
|
|
Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
|
|
CA2475356A1
|
|
Human fetal bladder-derived epithelial cells
|
|
AU2002327704A1
|
|
Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof
|
|
AU2103501A
|
|
Cell arrays and the uses thereof
|
|
US6987024B1
|
|
Human ovarian mesothelial cells and methods of isolation and uses thereof
|
|
US6436704B1
|
|
Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
|
|
US6416999B1
|
|
Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof
|
|
US6541225B1
|
|
Methods and compositions for generating human monoclonal antibodies
|
|
WO0037503A1
|
|
Compositions and methods for generating monoclonal antibodies representative of a specific cell type
|
